LAPTM4B通过PI3K/AKT信号通路促进肾细胞癌恶性增殖的作用及机制研究-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

LAPTM4B通过PI3K/AKT信号通路促进肾细胞癌恶性增殖的作用及机制研究

Study on the role and mechanism of LAPTM4B in promoting malignant proliferation of renal cell carcinoma via the PI3K/AKT signaling pathway

ES评分 4.5 浏览量：157 下载量：1

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20260207
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2026, 10(4)
作者	季清芬, 李朋, 赵冠安,
作者单位	丽水市人民医院浙江丽水;
摘要	目的研究LAPTM4B在肾细胞癌（RCC）中表达情况以及其激活PI3K/AKT信号传导机制促使肿瘤恶变增殖的作用机理。方法收集自2019年6月至2023年6月份在我院接受根治性肾切除手术的RCC患者的癌组织与癌旁正常组织样本各64份，以免疫组化染色法、Western blot及荧光定量PCR的方法检测LAPTM4B的表达量；建立LAPTM4B持续性下调的786-O细胞株，应用CCK-8法、克隆形成法以及流式细胞仪分析细胞增殖情况及其周期变化情况；运用Western blot检测PI3K/AKT信号通路主要蛋白的磷酸化状态；借助PI3K激活剂740Y-P进行救援实验以探索LAPTM4B影响肾细胞癌生长时是否经过PI3K-AKT途径。结果 LAPTM4B在肾癌组织中的表达量明显高于邻近正常肾组织（P<0.001）。而且较高的表达量也与肿瘤的临床分期、Fuhrman分级以及淋巴结转移密切相关（P<0.05）。敲低LAPTM4B之后，786-O细胞的生长活力显著减弱，G1相延迟增多，p-PI3K以及p-AKT蛋白水平同时减少，在加入740Y-P之后，这种抑制作用得到了一定的缓解，再次证明了LAPTM4B是通过活化PI3K/AKT信号网络来促进肾脏癌细胞的恶性增殖。结论 LAPTM4B在肾细胞癌高度过量表达，通过活化PI3K/AKT信号通路使得癌细胞发生恶性增殖，具有作为肾细胞癌治疗相关药物靶标的前景。
Abstract	Objective To investigate the expression of LAPTM4B in renal cell carcinoma (RCC) and the mechanism by which it activates the PI3K/AKT signaling pathway to promote tumor malignancy and proliferation. Methods Sixty-four pairs of tumor tissue and adjacent normal tissue samples from RCC patients who underwent radical nephrectomy in our hospital from June 2019 to June 2023 were collected. The expression level of LAPTM4B was detected by immunohistochemical staining, Western blot, and fluorescence quantitative PCR. A 786-O cell line with continuous down-regulation of LAPTM4B was established. The cell proliferation and its cycle changes were analyzed by CCK-8 assay, colony formation assay, and flow cytometry. The phosphorylation status of the main proteins of the PI3K/AKT signaling pathway was detected by Western blot. Rescue experiments with the PI3K activator 740Y-P were conducted to explore whether LAPTM4B affects the growth of renal cell carcinoma through the PI3K-AKT pathway. Results The expression level of LAPTM4B in renal cancer tissues was significantly higher than that in adjacent normal renal tissues (P < 0.001). Moreover, the higher expression level was also closely related to the clinical stage, Fuhrman grade, and lymph node metastasis of the tumor (P < 0.05). After knockdown of LAPTM4B, the growth vitality of 786-O cells was significantly weakened, the G1 phase was delayed, and the levels of p-PI3K and p-AKT proteins were simultaneously reduced. After adding 740Y-P, this inhibitory effect was alleviated, further confirming that LAPTM4B promotes the malignant proliferation of renal cell carcinoma cells by activating the PI3K/AKT signaling network. Conclusion LAPTM4B is highly overexpressed in renal cell carcinoma, and its activation of the PI3K/AKT signaling pathway leads to malignant proliferation of cancer cells, presenting a prospect as a target drug for renal cell carcinoma treatment.
关键词	肾细胞癌；LAPTM4B；PI3K/AKT信号通路；恶性增殖
KeyWord	Renal cell carcinoma; LAPTM4B; PI3K/AKT signaling pathway; Malignant proliferation
基金项目
页码	142-145

参考文献
相关文献

[1] 李彦伟.FHIT、LAPTM4B在NACT宫颈癌组织中的表达及其临床意义
[J].实用癌症杂志,2025,40(10):1583-1585+1590.

[2] 沈玲玲,刘黎明,陈东.三阴性乳腺癌组织中LAPTM4B和p27kip1的表达对患者临床病理特征和预后的影响
[J].中国医学工程,2025,33(07):37-42.

[3] 廖飞飞.活血解毒方调控LAPTM4B/mTORC1/TFEB通路介导的自噬流减轻心肌缺血再灌注损伤的研究
[D].北京中医药大学,2025.

[4] 黄沈莉.LAPTM4B单克隆抗体的制备及功能验证
[D].武汉工程大学,2025.

[5] 彭郭飞,江鹏,张丹平,等.能谱CT与血清LAPTM4B-35、KLF5联合检测对早期原发性肝癌患者的诊断价值
[J].影像科学与光化学,2024,42(06):610-616.

[6] 张永艳,夏妍芬,林佳慧,等.miR-518b靶向调控LAPTM4B在稽留流产发病中的作用
[J].郑州大学学报(医学版),2024,59(04):496-501.

[7] 沈磊.LAPTM4B-35介导的铁死亡参与胰腺导管腺癌吉西他滨的耐药研究
[D].安徽医科大学,2024.

[8] 黄永秀.LAPTM4B通过调节RPS9/STAT3轴促进AML进展
[D].重庆大学,2023.

引用本文

季清芬, 李朋, 赵冠安. LAPTM4B通过PI3K/AKT信号通路促进肾细胞癌恶性增殖的作用及机制研究 [J]. 国际临床研究杂志. 2026; 10; (4). 142 - 145.

文献评论

赵**

2026-10-15 08:32:34

本论文研究 LAPTM4B 在肾细胞癌（RCC）中表达情况以及其激活 PI3K/AKT 信号传导机制促使肿瘤恶变增殖的作用机理，发现LAPTM4B 在肾细胞癌高度过量表达，通过活化 PI3K/AKT 信号通路使得癌细胞发生恶性增殖，具有作为肾细胞癌治疗相关药物靶标的前景。不足之处有1.免疫组化、蛋白印迹、Q-PCR和细胞实验图片均未查见，使得文章结论和结果的可靠性存在折扣；2.本组肿瘤患者无随访数据，使得预后结论不得而知。

相关学者

相关机构